Ref No.: MUM/SEC/173-10/2021

October 23, 2020

To,

To,

General Manager

Vice President

Listing Department

Listing Department

BSE Limited

National Stock Exchange of India Limited

Phiroze Jeejeebhoy Tower,

Exchange Plaza, 5th Floor, Plot C/1,

Dalal Street, Fort

G Block, Bandra-KurlaComplex

Mumbai - 400001

Bandra (East), Mumbai - 400051

Scrip code: Equity (BSE: 540716/ NSE: ICICIGI); Debt (BSE: 954492/ NSE: ILGl26)

Dear Madam/Sir,

Sub: Outcome of the Board Meeting held on October 23, 2020

Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we wish to inform you that the Board of Directors of the Company, at their Meeting held today i.e. Friday, October 23, 2020 in Mumbai, have INTER-ALIA approved:

  • Audited Financial Results of the Company for the quarter and half-year ended
    September 30, 2020. A copy of the Audited Financial Results for the quarter and half-year ended September 30, 2020 together with the Statutory Auditors' Report in the prescribed format is enclosed herewith. A copy of the press release being issued in this connection is also attached.
  • Re-appointmentof Mr. Alok Kumar Agarwal (DIN: 03434304) as a Whole-time Director, designated as Executive Director-Wholesale of the Company, for a period of five (5) consecutive years or till the date of his retirement whichever is earlier effective from January 19, 2021, subject to approval of Insurance Regulatory and Development Authority of India and Members of the Company.

The Board has decided to seek the approval of Members of the Company through Postal Ballot for re-appointment of Mr. Alok Kumar Agarwal as a Whole-time Director, designated as Executive Director-Wholesale of the Company.

Further, pursuant to the requirements of Listing Regulations, please note the below details pertaining to re-appointment of Mr. Alok Kumar Agarwal as a Whole-time Director of the Company:

Mr. Alok Kumar Agarwal (DIN: 03434304)

Reason for change in

Re-appointment of Whole-time Director of the Company.

Directorship

Date

of

re-

Effective from January 19, 2021.

appointment

Brief Profile of Director

Mr. Alok Kumar Agarwal, aged 53 years, is an Executive

Director-Wholesale since January 19, 2011 at ICICI

Lombard General Insurance Company Limited ("the

Company"), the fifth largest player in the general insurance

sector as at March 31, 2020 (Source: GI Council Report).

Mr. Alok Kumar Agarwal heads the Wholesale Group at the

Company which includes the corporate and financial

inclusion business.

Mr. Alok Kumar Agarwal started his career in 1989 with

Reliance Industries Ltd. as an Engineer, Subsequently, he

worked with ICICI Ltd. for 9 years in project finance

department before shifting to ICICI Lombard General

Insurance Company Limited.

Mr. Alok Kumar Agarwal has completed Bachelor of

Chemical Engineering course from Jadavpur University. He

has also completed Post Graduate Diploma in Management

from the Indian Institute of Management, Kolkata.

Disclosure

of

Mr. Alok Kumar Agarwal is not related to any Director of the

relationship

between

Company.

Directors

Further, we affirm that Mr. Alok Kumar Agarwal (DIN: 03434304) has not been debarred from holding the office of director by virtue of any SEBI order or any other such authority.

The Meeting of the Board p.m.(IST) and concluded at

of Directors of the Company commenced at 2:30

4.33 p.m. (IST).

The above information is being made available on the Company's websitewww.icicilombard.com

You are requested to kindly take the same on records.

Yours Sincerely,

ICICI Lombard General Insurance Company Limited

Vikas Mehra Company Secretary

ICICI Lombard General Insurance Company Limited

CIN: L67200MH2000PLC129408

Registered Office Address: ICICI Lombard House, 414, Veer Savarkar Marg,

Near Siddhivinayak Temple, Prabhadevi, Mumbai-400025, Maharashtra

IRDAI Registration No. 115 dated August 3, 2001

[Pursuant to the Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with IRDAI Circular reference : IRDA/F&A/CIR/LFTD/027/01/2017 dated

30.01.2017]

Annexure-I

Statement of Audited Results for the Quarter and year to date ended September 30, 2020

( in lakhs)

Sl.

3 months ended / As at

Year to date ended / As at

Year ended / As at

No.

Particulars

September 30, 2020

June 30, 2020

September 30, 2019

September 30, 2020

September 30, 2019

March 31, 2020

Audited

Audited

Audited

Audited

Audited

Audited

OPERATING RESULTS

1

Gross Premiums written

325,451

339,421

303,067

664,872

659,133

1,359,237

2

Net Premium written 1

249,220

221,913

216,656

471,133

455,158

964,069

3

Premium Earned (Net)

246,252

232,384

235,692

478,636

460,181

940,352

4

Income from investments (net) 2

40,856

39,400

37,793

80,256

78,777

154,250

Other income

(a)

Foreign exchange gain / (loss)

73

101

78

174

49

302

5

(b)

Investment income from pool (Terrorism / Nuclear)

1,073

865

243

1,938

1,061

2,477

(c)

Contribution from Shareholders Funds towards excess EOM

-

-

-

-

-

7,508

(d)

Miscellaneous Income

86

217

86

303

239

387

6

Total income (3 to 5)

288,340

272,967

273,892

561,307

540,307

1,105,276

7

Commissions & Brokerage (net) 3

16,514

10,162

6,185

26,676

11,656

36,399

8

Net commission 3

16,514

10,162

6,185

26,676

11,656

36,399

Operating Expenses related to insurance business (a + b):

(a)

Employees' remuneration and welfare expenses

17,762

20,389

16,465

38,151

33,906

67,969

9

(b)

Other operating expenses (i+ii+iii)

i.

Advertisement and publicity

2,443

1,795

5,526

4,238

12,878

17,372

ii.

Sales promotion

29,425

20,872

19,282

50,297

35,652

86,251

iii.

Other expenses

15,071

13,184

13,399

28,255

26,336

57,718

10

Premium Deficiency

-

-

-

-

-

-

Incurred Claims

11

(a)

Claims Paid

120,027

108,131

134,795

228,158

240,378

512,917

(b)

Change in Outstanding Claims (Including IBNR/IBNER)

45,350

54,035

40,916

99,385

104,744

172,241

12

Total Expense (8+9+10+11)

246,592

228,568

236,568

475,160

465,550

950,867

13

Underwriting Profit/ (Loss) (3-12)

(340)

3,816

(876)

3,476

(5,369)

(10,515)

14

Provisions for doubtful debts (including bad debts written off)

-

-

-

-

-

-

15

Provisions for diminution in value of investments

-

-

-

-

-

-

16

Operating Profit/(Loss) (6-12)

41,748

44,399

37,324

86,147

74,757

154,409

Appropriations

17

(a)

Transfer to Profit and Loss A/c

41,748

44,399

37,324

86,147

74,757

154,409

(b)

Transfer to Reserves

-

-

-

-

-

-

NON-OPERATING RESULTS

Income in shareholders' account (a+b+c):

18

(a)

Transfer from Policyholders' Fund

41,748

44,399

37,324

86,147

74,757

154,409

(b)

Income from investments

12,362

11,448

11,927

23,810

24,615

46,444

(c)

Other income

9

2

6

11

11

1,557

19

Expenses other than those related to insurance business

5,348

2,179

2,348

7,527

4,077

15,886

20

Provisions for doubtful debts (including bad debts written off)

343

568

776

911

1,646

4,820

21

Provisions for diminution in value of investments

(7,029)

(2)

27

(7,031)

27

12,015

22

Total Expense (19+20+21)

(1,338)

2,745

3,151

1,407

5,750

32,721

23

Profit / (Loss) before extraordinary items (18-22)

55,457

53,104

46,106

108,561

93,633

169,689

24

Extraordinary Items

-

-

-

-

-

-

25

Profit/ (Loss) before tax (23-24)

55,457

53,104

46,106

108,561

93,633

169,689

26

Provision for tax

13,883

13,294

15,315

27,177

31,861

50,313

27

Profit / (Loss) after tax (PAT)

41,574

39,810

30,791

81,384

61,772

119,376

Dividend per share () (Nominal Value 10 per share)9

28

(a)

Interim Dividend

-

-

-

-

-

3.50

(b)

Final Dividend

-

-

-

-

3.50

3.50

29

Profit / (Loss) carried to Balance Sheet

485,915

444,341

366,102

485,915

366,102

404,531

30

Paid up equity capital

45,450

45,448

45,443

45,450

45,443

45,447

31

Reserve & Surplus (Excluding Revaluation Reserve)

649,545

607,805

529,401

649,545

529,401

567,957

32

Share Application Money Pending Allotment

35

-

10

35

10

21

33

Fair Value Change Account and Revaluation Reserve

21,918

(3,643)

10,123

21,918

10,123

(42,863)

34

Borrowings

48,500

48,500

48,500

48,500

48,500

48,500

Total Assets:

(a)

Investments:

35

- Shareholders' Fund

682,662

637,998

562,042

682,662

562,042

585,957

- Policyholders' Fund

2,233,533

2,173,803

1,837,888

2,233,533

1,837,888

2,046,716

(b)

Other Assets (Net of current liabilities and provisions)

(2,150,747)

(2,113,691)

(1,766,453)

(2,150,747)

(1,766,453)

(2,013,611)

Analytical Ratios 4 :

(i)

Solvency Ratio4a

2.74

2.50

2.26

2.74

2.26

2.17

(ii)

Expenses of Management Ratio4b

30.2%

25.2%

27.4%

27.6%

25.7%

26.6%

(iii)

Incurred Claim Ratio

67.2%

69.8%

74.6%

68.4%

75.0%

72.9%

(iv)

Net Retention Ratio

76.6%

65.4%

71.5%

70.9%

69.1%

70.9%

(v)

Combined Ratio

99.7%

99.7%

102.6%

99.8%

101.5%

100.4%

(vi)

Earning per share ()

(a) Basic and diluted EPS before extraordinary items (net of tax

Basic:

9.15

Basic:

8.76

Basic:

6.78

Basic:

17.91

Basic:

13.59

Basic:

26.27

expense) for the period 5

Diluted:

9.12

Diluted:

8.74

Diluted:

6.76

Diluted:

17.85

Diluted:

13.56

Diluted:

26.19

(b) Basic and diluted EPS after extraordinary items (net of tax

Basic:

9.15

Basic:

8.76

Basic:

6.78

Basic:

17.91

Basic:

13.59

Basic:

26.27

36

expense) for the period 5

Diluted: 9.12

Diluted: 8.74

Diluted: 6.76

Diluted: 17.85

Diluted: 13.56

Diluted: 26.19

(vii)

NPA ratios:

(a) Gross and Net NPAs

-

-

-

-

-

-

(b) % of Gross & Net NPAs

-

-

-

-

-

-

(viii)

Yield on Investments 5,6,7

(a) Without unrealized gains8

2.07%

1.78%

2.07%

3.90%

4.43%

7.94%

(b) With unrealised gains

2.24%

4.99%

1.87%

7.35%

4.79%

7.49%

(ix)

Public shareholding

(a) No. of shares

218,652,678

218,631,148

200,584,718

218,652,678

200,584,718

200,622,458

(b) Percentage of shareholding

48.11%

48.11%

44.14%

48.11%

44.14%

44.15%

(c) % of Government holding

-

-

-

-

-

-

(in case of public sector insurance companies)

-

-

-

-

-

-

Footnotes:

  1. Net of reinsurance (Including Excess of Loss Reinsurance).
  2. Including capital gains, net of amortisation and losses.
  3. Commission is net of commission received on reinsurance cession.
  4. Analytical ratios have been calculated as per definition given in IRDAI analytical ratios disclosures.
    4a The Solvency has been computed at the last day of the period.
    4b The Expenses of Management has been computed on the basis of Gross Direct Premium
  5. Not annualised
  6. Excludes unrealised gains or losses on real estate and unlisted equity
  7. Yield on investments with unrealised gains is computed using the modified Dietz method
  8. The computation is based on time weighted average book value.

Annexure-II

[Pursuant to the Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with IRDAI Circular reference : IRDA/F&A/CIR/LFTD/027/01/2017 dated

30.01.2017]

Segment1 Reporting for the Quarter and year to date ended September 30, 2020

( in lakhs)

Sl. No.

Particulars

3 months ended / As at

Year to date ended / As at

Year ended / As at

September 30, 2020

June 30, 2020

September 30, 2019

September 30, 2020

September 30, 2019

March 31, 2020

Audited

Audited

Audited

Audited

Audited

Audited

1 Segment Income:

(A) Fire

Net Premium Earned

12,522

9,607

6,192

22,129

10,962

27,358

Income from Investments

1,513

1,215

1,044

2,728

2,072

3,893

Other Income

812

807

173

1,619

802

1,779

(B) Marine

Net Premium Earned

5,309

5,969

6,391

11,278

12,233

25,632

Income from Investments

516

510

601

1,026

1,296

2,202

Other Income

(6)

29

(16)

23

32

17

(C) Health including Personal Accident*

(i) Health Retail

Net Premium Earned

18,206

17,433

17,565

35,639

34,420

69,655

Income from Investments

1,929

1,798

1,943

3,727

4,117

7,791

Other Income

8

15

8

23

17

7,464

(ii) Health Group, Corporate

Net Premium Earned

45,673

41,400

39,628

87,073

76,449

156,388

Income from Investments

4,051

3,777

3,538

7,828

7,330

13,850

Other Income

(49)

(25)

200

(74)

177

526

(iii) Health Government Business

Net Premium Earned

20

6

-

26

(6)

176

Income from Investments

74

57

84

131

100

253

Other Income

-

-

-

-

-

68

(D) Miscellaneous

(i) Miscellaneous Retail

Net Premium Earned

1,501

1,358

1,819

2,859

3,266

6,009

Income from Investments

741

752

940

1,493

2,004

3,540

Other Income

1

-

(4)

1

(3)

-

(ii) Miscellaneous Group, Corporate

Net Premium Earned

11,954

10,732

10,901

22,686

21,200

42,981

Income from Investments

1,625

1,571

1,592

3,196

3,302

6,238

Other Income

391

252

(11)

643

182

513

(E) Crop Insurance

Net Premium Earned

88

648

1,240

736

1,137

173

Income from Investments

812

803

418

1,615

740

1,968

Other Income

(1)

1

1

-

1

-

(F) Motor

Net Premium Earned

150,979

145,231

151,955

296,210

300,519

611,980

Income from Investments

29,595

28,917

27,634

58,512

57,817

114,515

Other Income

76

104

55

180

140

307

2

Premium Deficiency

(A) Fire

-

-

-

-

-

-

(B) Marine

-

-

-

-

-

-

(C) Health including Personal Accident*

(i) Health Retail

-

-

-

-

-

-

(ii) Health Group, Corporate

-

-

-

-

-

-

(iii) Health Government Business

-

-

-

-

-

-

(D) Miscellaneous

(i) Miscellaneous Retail

-

-

-

-

-

-

(ii) Miscellaneous Group, Corporate

-

-

-

-

-

-

(E) Crop Insurance

-

-

-

-

-

-

(F) Motor

-

-

-

-

-

-

3

Segment Underwriting Profit / (Loss):

(A) Fire

544

(1,172)

(143)

(628)

(898)

3,843

(B) Marine

(576)

(1,452)

449

(2,028)

278

1,328

(C) Health including Personal Accident*

(i) Health Retail

(3,251)

(1,324)

427

(4,575)

3,918

3,065

(ii) Health Group, Corporate

(1,948)

(3,026)

4,361

(4,974)

7,015

15,755

(iii) Health Government Business

-

(56)

364

(56)

346

981

(D) Miscellaneous

(i) Miscellaneous Retail

1,035

1,132

1,156

2,167

1,409

7,575

(ii) Miscellaneous Group, Corporate

334

909

3,520

1,243

3,117

5,886

(E) Crop Insurance

(123)

(235)

(800)

(358)

(928)

(345)

(F) Motor

3,645

9,040

(10,210)

12,685

(19,626)

(48,603)

( in lakhs)

Sl. No.

Particulars

3 months ended / As at

Year to date ended / As at

Year ended / As at

September 30, 2020

June 30, 2020

September 30, 2019

September 30, 2020

September 30, 2019

March 31, 2020

Audited

Audited

Audited

Audited

Audited

Audited

4

Segment Operating Profit / (Loss):

(A) Fire

2,869

850

1,074

3,719

1,976

9,514

(B) Marine

(66)

(913)

1,034

(979)

1,606

3,547

(C) Health including Personal Accident*

(i) Health Retail

(1,313)

488

2,377

(825)

8,052

18,320

(ii) Health Group, Corporate

2,054

726

8,100

2,780

14,522

30,131

(iii) Health Government Business

73

2

448

75

446

1,301

(D) Miscellaneous

(i) Miscellaneous Retail

1,776

1,885

2,092

3,661

3,410

11,115

(ii) Miscellaneous Group, Corporate

2,351

2,731

5,101

5,082

6,601

12,637

(E) Crop Insurance

689

568

(382)

1,257

(188)

1,625

(F) Motor

33,315

38,062

17,480

71,377

38,332

66,219

5

Segment Technical Liabilities:

Unexpired Risk Reserve - Net

(A) Fire

35,098

34,323

22,667

35,098

22,667

21,948

(B) Marine

8,450

8,481

9,142

8,450

9,142

6,071

(C) Health including Personal Accident*

(i) Health Retail

56,789

55,171

55,283

56,789

55,283

57,723

(ii) Health Group, Corporate

133,410

134,127

117,960

133,410

117,960

120,579

(iii) Health Government Business

54

68

-

54

-

-

(D) Miscellaneous

(i) Miscellaneous Retail

30,868

31,617

38,006

30,868

38,006

32,771

(ii) Miscellaneous Group, Corporate

27,235

27,458

26,078

27,235

26,078

25,285

(E) Crop Insurance

1

5

1

1

1

-

(F) Motor

284,408

282,095

285,939

284,408

285,939

319,439

Outstanding Claims Reserves Including IBNR &

IBNER - Gross

(A) Fire

222,588

204,109

174,922

222,588

174,922

194,589

(B) Marine

102,171

99,024

56,456

102,171

56,456

58,990

(C) Health including Personal Accident*

(i) Health Retail

41,279

37,344

33,863

41,279

33,863

32,026

(ii) Health Group, Corporate

99,360

82,174

62,529

99,360

62,529

63,254

(iii) Health Government Business

10,863

10,849

12,135

10,863

12,135

10,743

(D) Miscellaneous

(i) Miscellaneous Retail

3,726

3,670

3,420

3,726

3,420

3,634

(ii) Miscellaneous Group, Corporate

141,066

140,152

126,485

141,066

126,485

129,216

(E) Crop Insurance

96,959

102,838

279,477

96,959

279,477

252,894

(F) Motor

1,143,939

1,126,494

980,130

1,143,938

980,130

1,055,391

Footnote:

  1. Segments include : (A) Fire, (B) Marine, (C) Health including Personal Accident - (i) Health Retail, (ii) Health Group, and (iii) Health Government Schemes, (D) Miscellaneous - (i) Retail, (ii) Group / Corporate, (E) Crop Insurance, (F) Motor
  2. * includes Travel Insurance

Other Disclosures*

Status of Shareholders Complaints for the Quarter ended September 30, 2020

Sr No Particulars

Number

1

No. of Investor complaints pending at the beginning of period

0

2

No. of Investor complaints during the period

0

3

No. of Investor complaints disposed off during the period

0

4

No. of Investor complaints remaining unresolved at the end of the period

0

* The above disclosure is not required to be audited.

Notes forming part of Annexure I and Annexure II

  1. The above financial results of the Company for the quarter and year to date ended September 30, 2020 were reviewed and recommended by the Audit Committee and subsequently approved by the Board of Directors at its meetings held on October 23, 2020.
  2. The above financial results were audited by the joint statutory auditors, Chaturvedi & Co., Chartered Accountants and PKF Sridhar & Santhanam LLP, Chartered Accountants who have issued unmodified opinion on these financial results.
  3. During the quarter ended September 30, 2020, the Company has allotted 21,530 equity shares of face value of 10 each, pursuant to exercise of employee stock options granted earlier.
  4. During the quarter ended June 30, 2020, the company had made certain changes to its Employee Privilege Leave plan, introducing an option to encash accumulated leave on separation from the Company. Consequently, the additional charge, computed actuarially, for the quarter ended June 30, 2020 is 3,250 Lakhs, for the quarter ended September 30, 2020 is 91 Lakhs and year to date ended September 30, 2020 is 3,341 Lakhs.
  5. Other income (non-operating results) includes interest on income tax refund of 1,509 lakhs received for the year ended March 31, 2020 (for the quarter ended September 30, 2020 : NIL,
    for the quarter ended March 31, 2020 : NIL and for the quarter ended September 30, 2019 : NIL).
  6. During the quarter ended September 30, 2020, the Company has reversed previously assessed impairment of 7,029 Lakhs as underlying securities were sold, and the resultant losses were recognised. (During the quarter ended June 30, 2020, the Company reversed previously assessed impairment of 2 lakhs as underlying securities were realised. During the year ended March 31, 2020, the Company created an impairment provision of 12,015 lakhs on assessment of impairment of certain securities).
  7. The Company has used the principles of prudence in applying judgments, estimates and assumptions to assess and provide for the impact of the CoViD-19 pandemic on the interim condensed financial statements based on internal and external sources of information. However, due to the uncertainties associated with the pandemic, the actual impact may not be in line with the estimates as of the date of approval of the interim condensed financial statements. The Company will continue to closely monitor any changes to the estimates basis future economic conditions. Further, the impact assessment done by the company does not indicate any adverse impact on its ability to continue as a going concern.
  8. The Board of Directors of the Company at its Meeting held on August 21, 2020, have, inter alia, approved a Scheme of Arrangement amongst Bharti AXA General Insurance Company Limited ("Demerged Company" or "Bharti AXA") and ICICI Lombard General Insurance Company Limited ("Company") and their respective shareholders and creditors ("Scheme"), prepared pursuant to Sections 230 to 232, other applicable provisions of the Companies Act, 2013 read with the rules framed thereunder and Section 35 to 37 and other applicable provisions of the Insurance Act, 1938 (read with the rules and regulations framed thereunder). The Scheme provides inter alia for the demerger of the general insurance business of the Demerged Company into the Company as a going concern with effect from the Appointed Date i.e. April 1, 2020 and, as consideration for the demerger, the issue of 35,756,194 equity shares of the Company to the shareholders of the Demerged Company once the Scheme becomes effective.
    The Scheme is subject to, inter alia, applicable statutory and regulatory approvals including from Insurance Regulatory and Development Authority of India ("IRDAI"), Competition Commission of India, Stock Exchanges, Securities and Exchange Board of India, shareholders and creditors of the companies involved in the Scheme and the relevant jurisdictional benches of the National Company Law Tribunal and will take effect when final approval is received from IRDAI in accordance with the Insurance Act, 1938 read with the Insurance Regulatory Development Authority (Scheme of Amalgamation and Transfer of General Insurance Business) Regulations, 2011 and other rules and regulations framed thereunder.
    The Company has made necessary applications to, inter alia, the aforesaid regulators and stock exchanges seeking their approval for the Scheme and the process for receipt of these approvals is currently ongoing.
    During the quarter and year to date ended September 30, 2020, expenditure of 3,088 lakhs relating to demerger has been charged to profit and loss account under head "Expenses other than those related to insurance business".
  9. The Code on Social Security, 2020 ('Code') relating to employee benefits, during employment and post-employment, received Presidential assent on September 28, 2020. The Code has been published in the Gazette of India. However, the date on which the Code will come into effect has not been notified and the rules for quantifying the financial impact are yet to be framed. In view of this, the Company will assess and record the financial impact of the Code when it comes into effect.
  1. The IRDAI, vide its circular IRDA/F&A/CIR/MISC/099/04/2020 dated April 24, 2020 stipulated that, in view of the emerging market conditions and to conserve capital with the insurance companies in the interest of Policyholders and of the economy at large, has urged insurers to take conscious call to refrain from dividend pay-out from profits pertaining to the financial year ended March 31, 2020 till further instructions. This position shall be reassessed by the authority based on financial results of insurers for the quarter ending September 30, 2020. Accordingly, the Board of Directors has not declared any interim dividend for the year to date ended September 30, 2020.
  2. In view of the seasonality of Industry, the financial results for the quarters and year to date ended are not indicative of full year's expected performance.
  3. In accordance with requirements of IRDAI master circular on preparation of financial statements and filing of returns, the Company will publish the financials on the company's website latest by November 7, 2020.
  4. Figures of the previous year / quarters and year to date ended have been re-grouped /re-arranged to conform to current year / current quarter and year to date ended presentation.

For and on behalf of the Board

ICAI UDIN: 20040479AAAAGB3050

ICAI UDIN: 20201402AAAACG1422

Mumbai

Bhargav Dasgupta

October 23, 2020

Managing Director & CEO

ICICI Lombard General Insurance Company Limited

CIN: L67200MH2000PLC129408

Registered Office Address: ICICI Lombard House, 414, Veer Savarkar Marg,

Near Siddhivinayak Temple, Prabhadevi, Mumbai-400025, Maharashtra

IRDAI Registration No. 115 dated August 3, 2001

Balance Sheet

As at September 30, 2020

( in 000's)

Schedule

At

At

September 30, 2020

March 31, 2020

Sources of funds

Share capital

4,544,965

4,544,663

Reserves and Surplus

64,954,510

56,795,679

Share application money-pending allotment

3,456

2,145

Fair value change account

Shareholders funds

512,086

(948,118)

Policyholders funds

1,679,743

(3,338,180)

Borrowings

4,850,000

4,850,000

Total

76,544,760

61,906,189

Application of funds

Investments - Shareholders

68,266,206

58,595,714

Investments - Policyholders

223,353,300

204,671,553

Loans

-

-

Fixed assets

6,539,887

6,765,814

Deferred tax asset

4,146,652

3,063,067

Current assets

Cash and bank balances

268,531

326,362

Advances and other assets

80,873,698

96,998,375

Sub-Total (A)

81,142,229

97,324,737

Current liabilities

248,739,472

249,798,046

Provisions

58,164,042

58,716,650

Sub-Total (B)

306,903,514

308,514,696

Net current assets (C) = (A - B)

(225,761,285)

(211,189,959)

Miscellaneous expenditure (to the extent not written off or adjusted)

-

-

Debit balance in profit and loss account

-

-

Total

76,544,760

61,906,189

For and on behalf of the Board

Mumbai

Bhargav Dasgupta

October 23, 2020

Managing Director & CEO

Additional Disclosures as per Regulation 52(4) of SEBI (Listing Obligations and Disclosure

Requirements) Regulations, 2015

(` in Lakhs)

Particulars

At

At

At

September 30, 2020

September 30, 2019

March 31, 2020

Audited

Audited

Audited

Debt Equity Ratio

0.07

0.08

0.08

Debt Service Coverage Ratio

55.21

47.72

43.37

Interest Service Coverage

55.21

47.72

43.37

Ratio

Total Borrowings

48,500

48,500

48,500

Debenture Redemption

2,771

2,771

2,771

Reserve4

Net Worth

694,995

574,844

613,403

Notes:

  1. Credit Rating:"AAA" by CRISIL and "AAA" by ICRA
  2. Previous due date for payment of interest on Non-Convertible Debentures : July 28, 2020.
  3. Next due date for payment of interest on Non-Convertible Debentures : July 28, 2021 , Amount : ` 4,001 Lakhs
  4. The Company has been creating Debenture Redemption Reserve (DRR) on a straight-line basis. Pursuant to amendment vide Ministry of Corporate Affairs notification no. G,S.R. 574(E) dated August 16, 2019 of Companies (Share Capital and Debenture) Rules, 2014, the Company is not required to create any additional DRR. Accordingly the Company continues to hold the existing DRR of ₹ 2,771 lacs.

For and on behalf of the Board

Mumbai

Bhargav Dasgupta

October 23, 2020

Managing Director & CEO

ICICI Lombard General Insurance Company Limited

IRDAI Registration No. 115 dated August 3, 2001 CIN: L67200MH2000PLC129408

Registered Address: ICICI Lombard House, 414, Veer Savarkar Marg, Near Siddhivinayak Temple, Prabhadevi Mumbai-400025, Maharashtra

(` in 000's)

Direct basis

For the half year ended September 30, 2020

  1. CASH FLOW FROM OPERATING ACTIVITIES
  1. - Premium received from policyholders, including advance receipt
  2. - Other receipts (including-environment relief fund & Terrorism Pool)
  3. - Receipt / (payment) from/to re-insurer net of commissions & claims recovery
  4. - Receipt / (payment) from / to co-insurer net of claims recovery
  5. - Payments of claims (net of salvage)
  6. - Payments of commission and brokerage
  7. - Payments of other operating expenses *2
  8. - Preliminary and preoperative expenses
  9. - Deposits, advances & staff loans (net)
  1. - Income tax paid (net)
  2. - Service taxes / Goods and service tax paid
  3. - Cash flows before extraordinary items
  4. - Cash flows from extraordinary operations
  5. Net cash from operating activities
  1. CASH FLOW FROM INVESTING ACTIVITIES
  1. - Purchase of fixed assets (including capital advances)
  2. - Proceeds from sale of fixed assets
  3. - Purchase of investments
  4. - Loans disbursed
  5. - Sale of investments
  6. - Repayments received
  7. - Rent/interest/dividends received
  8. - Investments in money market instruments &

mutual fund (net)

9 - Other payments (Interest on IMTPIP)

  1. - Other payments (Advance payment for purchase of real estate)
  2. - Expenses related to investments
  3. - Other (Deposit received on leasing of premises)
  4. Net cash from investing activities
  1. CASH FLOW FROM FINANCING ACTIVITIES
  1. - Proceeds from issuance of share capital / application money (including share premium & net of share issue expenses)
  2. - Proceeds from borrowing
  3. - Repayments of borrowing
  4. - Brokerage and other expenses on borrowings
  5. - Interest / Dividends paid
  6. Net cash from financing activities

Effect of foreign exchange rates on cash and cash equivalents,

  1. net
  2. Net increase/(decrease) in cash and cash equivalents
    1 Cash and cash equivalents at the beginning of the year
    2 Cash and cash equivalents at end of the period*1

Half year ended

Half year ended

September 30, 2020

September 30, 2019

82,197,873

80,649,353

228,997

134,639

(2,944,733)

(3,241,687)

2,772,368

2,024,723

(41,697,999)

(36,283,396)

(6,269,619)

(6,719,245)

(12,147,576)

(13,267,508)

-

-

(1,424,362)

(1,644,341)

(3,054,310)

(3,432,642)

(6,212,865)

(7,309,272)

11,447,774

10,910,624

-

-

11,447,774

10,910,624

(416,269)

(442,099)

3,249

(413,020)

1,154

(440,945)

(84,660,033)

(62,630,678)

-

-

60,490,643

52,907,332

-

-

9,272,195

7,820,080

4,205,332

(7,712,447)

-

-

-

-

(23,693)

(20,529)

-

(10,715,556)

-

(9,636,242)

(11,128,576)

(10,077,187)

22,054

21,004

-

-

-

-

-

-

(399,083)

(2,316,238)

(377,029)

(2,295,234)

-

-

(57,831)

(1,461,797)

326,362

4,016,466

268,531

2,554,669

*1 Cash and cash equivalent at the end of the period includes short term deposits of 1,590 thousand (previous period: 1,590 thousand) balances with banks in

current accounts 238,356 thousand (previous period: 2,195,777 thousand) and cash including cheques and stamps in hand amounting to 28,585 thousand

(previous period: 357,302 thousand)

*2 Includes payments towards Corporate Social Responsibility of 150,000 thousand (previous period: 117,420 thousand)

For and on behalf of the Board

Mumbai

Bhargav Dasgupta

October 23, 2020

Managing Director & CEO

Chaturvedi & Co.

PKF Sridhar & Santhanam LLP

Chartered Accountants

Chartered Accountants

81, Mittal Chambers,

201, 2nd Floor, Center Point Building,

228, Nariman Point,

Dr. BR Ambedkar Road,

Mumbai - 400021

Parel, Mumbai - 400012

Independent Auditors' Report on Quarterly and Year to Date Financial Results of ICICI Lombard General Insurance Company Limited pursuant to the Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Insurance Regulatory and Development Authority of India circular reference number IRDA /F&A /CIR/ LFTD/027/01/2017 dated January 30, 2017

To The Board of Directors of

ICICI Lombard General Insurance Company Limited

Report on the audit of the Financial Results

Opinion

  1. We have audited the accompanying quarterly and year to date financial results of ICICI Lombard General Insurance Company Limited (the "Company") for the quarter ended 30th September 2020 results for the period from 1st July 2020 to 30th September 2020 and the year to date results for the period from 1st April 2020 to 30th September 2020 attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India ("SEBI") (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("SEBI Listing Regulations") and Insurance Regulatory and Development Authority ('IRDAI" or "Authority") circular reference number IRDA /F&A /CIR/ LFTD/ 027 / 01/ 2017 dated January 30, 2017.
  2. In our opinion and to the best of our information and according to the explanations given to us these financial results:
    1. are presented in accordance with the requirements of Regulation 33 of the SEBI Listing Regulations and IRDAI Circular reference number IRDA /F&A /CIR/ LFTD/ 027 / 01/ 2017 dated January 30, 2017; and
    2. give a true and fair view in conformity with the recognition and measurement principles laid down in Accounting Standard ("AS") 25, "Interim Financial Reporting" ("AS 25"), prescribed under Section 133 of the Companies Act (the "Act"), including relevant provisions of the Insurance Act, 1938 (the "Insurance Act"), the Insurance Regulatory and Development Authority of India Act, 1999 (the "IRDAI Act") and other accounting principles generally accepted in India, to the extent considered relevant and appropriate for the purpose of these financial results and which are not inconsistent with the accounting principles as prescribed in the Insurance Regulatory and Development Authority of India (Preparation of Financial Statements and Auditors' Report of Insurance Companies) Regulations, 2002 (the "IRDAI Accounting Regulations") and orders/directions/circulars issued by the IRDAI, to the extent applicable, of the net profit and other financial information for the quarter and year to date ended 30 September 2020.

RSN

Chaturvedi & Co.

PKF Sridhar & Santhanam LLP

Chartered Accountants

Chartered Accountants

Basis for Opinion

3. We conducted our audit in accordance with the Standards on Auditing ("SAs") specified under section 143(10) of the Companies Act, 2013 (the Act). Our responsibilities under those Standards are further described in the Auditor's Responsibilities for the Audit of the Interim Financial Results section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the financial results under the provisions of the Companies Act, 2013 and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Management's Responsibilities for the Interim Financial Results

  1. These quarterly and year to date financial results have been prepared on the basis of the interim condensed financial statements. The Company's Board of Directors are responsible for the preparation of these financial results that give a true and fair view of the net profit and other financial information in accordance with the recognition and measurement principles laid down in AS 25, 'Interim Financial Reporting' prescribed under Section 133 of the Act read with relevant rules issued thereunder, the Insurance Act, the IRDAI Act, the IRDAI Accounting Regulations and orders / directions prescribed by the IRDAI in this behalf, current practices prevailing within the insurance industry in India and other accounting principles generally accepted in India and in compliance with Regulation 33 of the SEBI Listing Regulations. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial controls that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the financial results that give a true and fair view and are free from material misstatement, whether due to fraud or error.
  2. In preparing the financial results, the Board of Directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Board of Directors either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.
  3. The Board of Directors are also responsible for overseeing the Company's financial reporting process.

Auditor's Responsibilities for the Audit of the Interim Financial Results

7. Our objectives are to obtain reasonable assurance about whether the financial results as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial results.

RSN

Chaturvedi & Co.

PKF Sridhar & Santhanam LLP

Chartered Accountants

Chartered Accountants

  1. As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:
    • Identify and assess the risks of material misstatement of the financial results, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
    • Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company's internal control.
    • Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the Board of Directors.
    • Conclude on the appropriateness of the Board of Directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the financial results or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.
    • Evaluate the overall presentation, structure and content of the financial results, including the disclosures, and whether the financial results represent the underlying transactions and events in a manner that achieves fair presentation.
  2. Materiality is the magnitude of misstatements in the financial results that, individually or in aggregate, makes it probable that the economic decisions of a reasonably knowledgeable user of the financial results may be influenced. We consider quantitative materiality and qualitative factors in (i) planning the scope of our audit work and in evaluating the results of our work; and (ii) to evaluate the effect of any identified misstatements in the financial results.
  3. We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
  4. We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

RSN

Chaturvedi & Co.

PKF Sridhar & Santhanam LLP

Chartered Accountants

Chartered Accountants

Other Matters

12. The actuarial valuation of liabilities in respect of Incurred But Not Reported (the "IBNR"), Incurred But Not Enough Reported (the "IBNER") and Premium Deficiency Reserve (the "PDR") is the responsibility of the Company's Appointed Actuary (the "Appointed Actuary"). The actuarial valuation of these liabilities, that are estimated using statistical methods as at September 30, 2020 has been duly certified by the Appointed Actuary and in his opinion, the assumptions considered by him for such valuation are in accordance with the guidelines and norms issued by the IRDAI and the Institute of Actuaries of India in concurrence with the IRDAI. We have relied upon the Appointed Actuary's certificate in this regard for forming our opinion on the valuation of liabilities for outstanding claims reserves and the PDR contained in the financial results of the Company.

For Chaturvedi & Co.

For PKF Sridhar & Santhanam LLP

Chartered Accountants

Chartered Accountants

(Firm Registration No. 302137E)

(Firm Registration No. 003990S/S200018)

(S N Chaturvedi)

(R. Suriyanarayanan)

Partner

Partner

Membership No. 040479

Membership No. 201402

UDIN: 20040479AAAAGB3050

UDIN: 20201402AAAACG1422

Place: Mumbai

Date: 23 October, 2020

October 23, 2020

PERFORMANCE FOR THE HALF YEAR ENDED SEPTEMBER 30, 2020

  • Gross Direct Premium Income (GDPI) of the Company stood at ` 64.91 billion in H1 FY2021 compared to ` 64.40 billion in H1 FY2020, a growth of 0.8%. Excluding crop segment, GDPI of the Company increased to ` 64.59 billion in H1 FY2021 compared to ` 63.86 billion in H1 FY2020, registering a growth of 1.1%. This was lower than the industry growth (excluding crop segment) of 2.8%. The industry growth has been muted due to Covid-19 pandemic.
    1. GDPI of the Company stood at ` 31.89 billion in Q2 FY2021 compared to
      ` 29.53 billion in Q2 FY2020, a growth of 8.0%. Excluding crop segment, GDPI of the Company increased to ` 31.86 billion in Q2 FY2021 compared to ` 28.98 billion in Q2 FY2020, registering a growth of 9.9%. This was higher than the industry growth (excluding crop segment) for Q2 FY2021 of 9.2%.
  • Combined ratio stood at 99.8% in H1 FY2021 compared to 101.5% in H1 FY2020 despite losses incurred from cyclone and floods. Excluding the impact of cyclone and flood losses of 0.77 billion, the combined ratio was 98.2% in H1 FY2021 as against 100.1% in H1 FY2020 excluding the impact of cyclone and flood losses of 0.61 billion.
    1. Combined ratio stood at 99.7% in Q2 FY2021 compared to 102.6% in Q2 FY2020. Excluding the impact of flood and cyclone losses of 0.46 billion, the combined ratio was 97.9% in Q2 FY2021 as against 100.7% in Q2 FY2020 excluding the impact of cyclone and flood losses of 0.45 billion.
  • Profit before tax (PBT) grew by 15.9% to ` 10.86 billion in H1 FY2021 from ` 9.36 billion in H1 FY2020 whereas PBT grew by 20.3% to ` 5.55 billion in Q2 FY2021 compared to ` 4.61 billion in Q2 FY2020.
    1. Capital gains were lower at ` 1.84 billion in H1 FY2021 compared to ` 2.07 billion in H1 FY2020. Capital gains were at ` 1.24 billion in Q2 FY2021 compared to ` 0.69 billion in Q2 FY2020.
  • Consequently, Profit after tax (PAT) grew by 31.7% to ` 8.14 billion in H1 FY2021 as against ` 6.18 billion in H1 FY2020 whereas PAT grew by 35.0% to ` 4.16 billion in Q2 FY2021 from ` 3.08 billion in Q2 FY2020.
  • Return on Average Equity (ROAE) was 24.9% in H1 FY2021 compared to 22.3% in H1 FY2020 while ROAE was 24.7% in Q2 FY2021 compared to 22.0% in Q2 FY2020.
  • Solvency ratio was 2.74x at September 30, 2020 as against 2.50x at June 30, 2020 and higher than the minimum regulatory requirement of 1.50x. Solvency ratio was 2.17x at March 31, 2020.

Operating Performance Review

(` billion)

Financial

Q2

Q2

Growth

H1

H1

Growth

Indicators

FY2020

FY2021

FY2020

%

FY2021

FY2020

%

GDPI

31.89

29.53

8.0%

64.91

64.40

0.8%

133.13

PBT

5.55

4.61

20.3%

10.86

9.36

15.9%

16.97

PAT

4.16

3.08

35.0%

8.14

6.18

31.7%

11.94

Ratios

Financial Indicators

Q2

Q2

H1

H1

FY2020

FY2021

FY2020

FY2021

FY2020

ROAE (%) - Annualised

24.7%

22.0%

24.9%

22.3%

20.8%

Combined ratio (%)

99.7%

102.6%

99.8%

101.5%

100.4%

Notes:

Combined Ratio = (Net Incurred Claims/ Net Earned Premium) + (Management Expenses - Commission on Reinsurance)/ Net Written Premium

Management Expenses = Commission Paid Direct + Commission Paid on Reinsurance inward + Operating expenses related to insurance business

Return on Average Equity (ROAE) = Profit After Tax / ((Opening Net Worth + Closing Net Worth)/2)

Net Worth = Share Capital + Reserves & Surplus

About ICICI Lombard General Insurance Company Limited

We are one of the leading private sector non- life insurers in India. We offer our customers a comprehensive and well-diversified range of products, including motor, health, crop, fire, personal accident, marine, engineering and liability insurance, through multiple distribution channels. More details are available at www.icicilombard.com

For further press queries please get in touch with Ms. Seema Jadhav +91 70459 26209 or email to corporate.communication@icicilombard.com

For investor queries please get in touch with Mr. Sarvesh Agrawal +91 70450 91174 or send an email to sarvesh.agrawal@icicilombard.com/ ir@icicilombard.com

Disclaimer

Except for the historical information contained herein, statements in this release which contain words or phrases such as 'will', 'expected to', etc., and similar expressions or variations of such expressions may constitute 'forward-looking statements'. These forward-looking statements involve a number of risks, uncertainties and other factors that could cause actual results, opportunities and

growth potential to differ materially from those suggested by the forward-looking statements. These risks and uncertainties include, but are not limited to, the actual growth in demand for insurance and other related services in the countries that we operate or where a material number of our customers reside, the continued service of our senior management, our ability to successfully implement our strategy, including our use of the Internet and other technology our exploration of merger and acquisition opportunities, our ability to integrate mergers or acquisitions into our operations and manage the risks associated with such acquisitions to achieve our strategic and financial objectives, our growth and expansion in domestic and overseas markets, technological changes, our ability to market new products, the outcome of any legal, tax or regulatory proceedings in India and in other jurisdictions we are or become a party to, the outcome of any internal or independent enquiries or regulatory or governmental investigations, investment income, cash flow projections, impact of competition; the impact of changes in capital, solvency ratio, exposure to reputational risk, the future impact of new accounting standards, our ability to implement our dividend policy, the impact of changes in insurance regulations and other regulatory changes in India and other jurisdictions on us. ICICI Lombard General Insurance Company Limited undertakes no obligation to update forward-looking statements to reflect events or circumstances after the date thereof.

Attachments

  • Original document
  • Permalink

Disclaimer

ICICI Bank Ltd. published this content on 23 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 October 2020 09:29:07 UTC